Packard BioScience Buying GSI Lumonics Life Science Group
MERIDEN, Conn., Aug. 25 -- In a move to strengthen its position as a provider of biochips and microarray analysis tools, Packard BioScience Co. will purchase a unit of GSI Lumonics Inc.'s GSLI Life Sciences unit for $40 million in cash and $80 million in Packard stock.
The GSLI Life Sciences unit will provide Packard BioScience with the necessary laser detection and data analysis tools needed to extract results from microarray experiments.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024